Furthermore, chi-square tests suggested that GRSF1 upregulation was positively correlated with larger tumor size (p<0.01), worse differentiation (p<0.05), microscopic vascular invasion (p<0.01) and advanced TNM stage in HCC (p<0.01, Table S3). The gene discussed is GRSF1; the disease is hepatocellular carcinoma.